Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.882 | 0.040 | 13 | 33017018 | missense variant | A/G | snv | 4.8E-06 | 7.0E-06 |
|
0.800 | 1.000 | 1 | 2007 | 2007 | |||||||
|
13 | 33039909 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
13 | 33039909 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
13 | 33039909 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
13 | 33061698 | missense variant | T/A;C | snv | 8.0E-06; 0.99 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
13 | 33061698 | missense variant | T/A;C | snv | 8.0E-06; 0.99 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
13 | 33061698 | missense variant | T/A;C | snv | 8.0E-06; 0.99 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.882 | 0.040 | 13 | 33017018 | missense variant | A/G | snv | 4.8E-06 | 7.0E-06 |
|
0.700 | 0 | ||||||||||
|
1.000 | 0.080 | 13 | 33064008 | missense variant | C/A;T | snv | 4.0E-06; 9.1E-05 |
|
Digestive System Diseases; Neoplasms | 0.700 | 0 | ||||||||||
|
1.000 | 0.080 | 13 | 33061802 | intron variant | T/A | snv | 0.82 | 0.81 |
|
Cardiovascular Diseases | 0.020 | 1.000 | 2 | 2010 | 2018 | ||||||
|
0.925 | 0.120 | 13 | 33016046 | upstream gene variant | G/A | snv | 0.17 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.120 | 13 | 33016046 | upstream gene variant | G/A | snv | 0.17 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.120 | 13 | 33016046 | upstream gene variant | G/A | snv | 0.17 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.882 | 0.040 | 13 | 33017018 | missense variant | A/G | snv | 4.8E-06 | 7.0E-06 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
|
1.000 | 0.040 | 13 | 33020990 | intron variant | G/A;C | snv |
|
Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||||
|
1.000 | 0.040 | 13 | 33022051 | intron variant | A/G;T | snv |
|
Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||||
|
1.000 | 0.040 | 13 | 33019132 | intron variant | T/C | snv | 0.15 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.040 | 13 | 33019132 | intron variant | T/C | snv | 0.15 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.040 | 13 | 33015697 | upstream gene variant | A/- | del | 0.21 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2020 | 2020 | |||||||
|
1.000 | 0.040 | 13 | 33015697 | upstream gene variant | A/- | del | 0.21 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2020 | 2020 | |||||||
|
1.000 | 0.040 | 13 | 33015697 | upstream gene variant | A/- | del | 0.21 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2020 | 2020 | |||||||
|
1.000 | 0.040 | 13 | 33015697 | upstream gene variant | A/- | del | 0.21 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2020 | 2020 | |||||||
|
0.882 | 0.120 | 13 | 33055256 | missense variant | C/T | snv | 2.9E-02 | 1.5E-02 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.882 | 0.120 | 13 | 33055256 | missense variant | C/T | snv | 2.9E-02 | 1.5E-02 |
|
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.882 | 0.120 | 13 | 33055256 | missense variant | C/T | snv | 2.9E-02 | 1.5E-02 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 |